Back to top

GH Maintained by Morgan Stanley -- Price Target Raised to $175

GH Maintained by Morgan Stanley -- Price Target Raised to $175

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Guardant Health, Inc. (GH)